Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1LJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,096
Award facts
- Contract value 100% obligated
- $44,095.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,095.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Gemtesa 75 mg tablets (90-count units), with completion scheduled for January 28, 2026. This non-set-aside award was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities across multiple therapeutic domains to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to supply brand-name and generic medications, vaccines, and specialized medical supplies through competitive procurement processes. This delivery order for Gemtesa, a medication used in the treatment of overactive bladder, reflects the ongoing pharmaceutical procurement needs of the Department of Defense healthcare system and represents routine fulfillment of medical supply requirements under the established DLA Medical Supply Chain framework.
Quick answers
Who was awarded contract SPE2DR26FA1LJ?
SPE2DR26FA1LJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FA1LJ worth?
The government has obligated $44,096 on SPE2DR26FA1LJ.
Is contract SPE2DR26FA1LJ an order under another contract?
Yes. SPE2DR26FA1LJ is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1LJ competed?
The extent of competition for SPE2DR26FA1LJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award